PERNIX THERAPEUTICS HOLDINGS, INC. - FORM 10-K - EX-32.1 - 906 CERTIFICATE - March 28, 2017

Attached files

file filename
EX-10.3 - AMENDED AND RESTATED GOLF TRUST OF AMERICA, INC. 2007 STOCK OPTION PLAN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-3.htm
EX-31.2 - CFO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-2.htm
EX-31.1 - CEO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-1.htm
EX-23.1 - CONSENT - PERNIX THERAPEUTICS HOLDINGS, INC.exh23-1.htm
EX-21.1 - SUBSIDIARIES - PERNIX THERAPEUTICS HOLDINGS, INC.exh21-1.htm
EX-10.35 - RESTRICTED SHARE UNIT AGREEMENT UNDER THE AMENDED AND RESTATED PERNIX THERAPEUTI - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-35.htm
EX-10.34 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT UNDER THE AMENDED AND RESTATED - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-34.htm
EX-10.33 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT UNDER THE AMENDED AND RESTATED - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-33.htm
EX-10.32 - OFFER LETTER, DATED DECEMBER 16, 2016, BY AND BETWEEN PERNIX THERAPEUTICS HOLDIN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-32.htm
EX-10.30 - FORM OF INDEMNIFICATION AGREEMENT BETWEEN PERNIX THERAPEUTICS HOLDINGS, INC. AND - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-30.htm
EX-10.17 - AMENDED AND RESTATED PERNIX THERAPEUTICS HOLDINGS, INC. 2015 OMNIBUS INCENTIVE P - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-17.htm
EX-10.2 - AMENDED AND RESTATED 2010 EMPLOYEE STOCK PURCHASE PLAN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-2.htm
EX-10.1 - AMENDED AND RESTATED 2009 STOCK INCENTIVE PLAN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-1.htm
10-K - 10-K - PERNIX THERAPEUTICS HOLDINGS, INC.body10k.htm

EXHIBIT 32.1

CERTIFICATION UNDER SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in this annual report fairly presents, in all material respects, the financial condition and results of operations of Pernix Therapeutics Holdings, Inc. for the periods covered by this annual report.

Date: March 28, 2017

 

/s/ JOHN SEDOR

 

 

 

John Sedor

 

 

 

Chairman and Chief Executive Officer
(Principal Executive Officer)

 

 

 

 

 

Date: March 28, 2017

 

/s/ GRAHAM MIAO

 

 

 

Graham Miao
President and Chief Financial Officer

 

 

 

(Principal Financial Officer)

 

 

PERNIX THERAPEUTICS HOLDINGS, INC. Reports